Moderna, inc. (MRNA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Operating activities
Net loss

-505,654

-514,000

-532,297

-489,434

-444,900

-384,700

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

83,038

81,122

92,437

86,353

79,211

72,565

0

0

0

Depreciation, Depletion and Amortization

31,121

31,021

29,444

28,679

26,962

24,862

0

0

0

Amortization/accretion of investments

2,222

3,742

4,191

3,695

2,788

1,866

0

0

0

Loss on disposal of property and equipment

-434

-316

-961

-905

-910

-891

0

0

0

Changes in assets and liabilities:
Accounts receivable

-29

-6,654

-7,045

-7,894

-2,359

-195

0

0

0

Accounts receivable from related party

718

-562

3,704

250

-29,100

-637

0

0

0

Prepaid expenses and other assets

-2,092

-9,751

1,450

-5,898

-306

5,289

0

0

0

Right-of-use assets, operating leases

0

-

-

-

0

-

-

-

-

Accounts payable

-23,364

-23,964

-4,886

14,886

15,281

15,017

0

0

0

Accrued liabilities

16,242

-3,362

17,724

5,950

13,261

8,787

0

0

0

Deferred revenue

0

-

0

0

0

-

0

0

0

Deferred lease obligation

-

-

-

-

-

2,420

0

0

0

Operating lease liabilities

0

-

-

-

0

-

-

-

-

Other liabilities

-1,248

-6,169

1,673

171

1,538

910

0

0

0

Net cash used in operating activities

-420,891

-458,968

-454,215

-427,378

-363,748

-330,865

0

0

0

Investing activities
Purchases of marketable securities

1,336,966

1,145,226

1,225,792

1,233,038

996,987

1,227,709

0

0

0

Proceeds from maturities of marketable securities

858,974

993,181

1,037,694

1,048,631

997,499

783,373

0

0

0

Proceeds from sales of marketable securities

188,970

168,654

87,507

105,960

179,791

177,008

0

0

0

Purchases of property and equipment

30,182

31,554

38,529

57,958

81,452

105,766

0

0

0

Net cash used in investing activities

-319,204

-14,945

-139,120

-136,405

98,851

-373,094

0

0

0

Financing activities
Proceeds from public offering of common stock, net of issuance costs

0

-

-

-

0

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

661,111

0

0

0

Proceeds from issuance of common stock through equity plans, net

75,559

47,259

20,608

5,344

1,462

1,427

0

0

0

Charges to financing lease obligation

0

-

-

-

0

-

-

-

-

Reimbursement of assets under financing lease obligation

-

-

-

-

-

11,635

0

0

0

Payments on financing lease obligation

-

-

-

-

-

2,175

0

0

0

Net cash provided by financing activities

628,881

51,121

599,446

574,249

677,140

1,226,842

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

-111,214

-422,792

6,111

10,466

412,243

522,883

0

0

0

Non-cash investing and financing activities
Issuance costs included in accounts payable and accrued liabilities

-

-

-

-

-

-

-

-

0

Purchases of property and equipment included in accounts payable and accrued liabilities

-2,841

4,676

1,987

-9,215

-1,508

12,892

0

0

0

Leasehold improvements included in prepaid and other current assets

-

-

-

-

-

10,089

0

0

0

Lease financing obligation

-

-

-

-

-

10,089

0

0

0